1. Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial. (28th August 2019) Authors: Bartlett, J M S; Sgroi, D C; Treuner, K; Zhang, Y; Ahmed, I; Piper, T; Salunga, R; Brachtel, E F; Pirrie, S J; Schnabel, C A; Rea, D W Journal: Annals of oncology Issue: Volume 30:Number 11(2019) Page Start: 1776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗